Tuesday, 23 June 2026European Markets

#AI drug discovery

7 articles

Novo Nordisk Closes Cell Therapy Unit, Outsources Parkinson's to AI-Native Partner

European Pharma

Novo Nordisk Closes Cell Therapy Unit, Outsources Parkinson's to AI-Native Partner

Salvado•Jun 19, 2026

Novo Nordisk Outsources Parkinson's Programs to AI Partner as Stock Surges 24.9%

European Pharma

Novo Nordisk Outsources Parkinson's Programs to AI Partner as Stock Surges 24.9%

Salvado•Jun 9, 2026

Novo Nordisk Licenses Parkinson's Therapy to AI Startup, Shares Rise 24.9% in 30 Days

European Pharmaceutical Innovation

Novo Nordisk Licenses Parkinson's Therapy to AI Startup, Shares Rise 24.9% in 30 Days

Salvado•Jun 5, 2026

Novo Nordisk's 24.9% Rally Backs AI Partnership Model Over In-House Biology

European Pharma

Novo Nordisk's 24.9% Rally Backs AI Partnership Model Over In-House Biology

Salvado•May 31, 2026

Novo Nordisk Stock Surges 24.9% in 30 Days as AI Reshapes European Drug Discovery

European Pharma

Novo Nordisk Stock Surges 24.9% in 30 Days as AI Reshapes European Drug Discovery

Salvado•May 27, 2026

Novo Nordisk Closes Cell Therapy Unit, Outsources Parkinson's to AI Partner as Stock Surges 25%

European Pharmaceutical Innovation

Novo Nordisk Closes Cell Therapy Unit, Outsources Parkinson's to AI Partner as Stock Surges 25%

Salvado•May 18, 2026

Novo Nordisk Stock Jumps 24.9% After Closing Cell Therapy Unit and Licensing Parkinson's Program to AI Partner

European Pharma

Novo Nordisk Stock Jumps 24.9% After Closing Cell Therapy Unit and Licensing Parkinson's Program to AI Partner

Salvado•May 13, 2026